ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,660, issued on March 4, was assigned to Viscera Labs Inc..
"Therapeutic composition and methods" was invented by Stephen Taglienti (Ledgewood, N.J.) and Steven L. Petruccelli (Watchung, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example pruritus, a disorder related to elevated serum cholesterol concentration, or reducing elevated low-density lipoprotein cholesterol (LDL) concentration in a patient."
The patent was filed on Sept. 25, 2023, under Application No. 18/372,162.
*For further information, including imag...